Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Exempting Generic Drug Makers from Lawsuits
The Supreme Court recently ruled that generic drug makers cannot be sued on the grounds of adverse side effects if their product warning labels are the same as those from the brand-name manufacturers. The court overruled a multimillion dollar jury award to a woman in New Hampshire who was severely disfigured after taking a generic anti-inflammatory. In effect, the Supreme Court said the federal law trumps state law.